Animal Feed · Founded 1963 · www.kselimited.com · BSE 519421 · NSE KSE LIMITED · ISIN INE953E01022
No Notes Added Yet
Business
KSE Ltd. is an Indian diversified agri-business company primarily engaged in the manufacturing and sale of compound animal feed. Its core business involves producing and marketing various types of animal feed, including cattle feed and poultry feed. Beyond animal feed, the company also operates in the solvent extraction and edible oil segment, producing crude oils, refined edible oils, and de-oiled cakes (which often serve as raw material for its feed division). Additionally, KSE Ltd. has a dairy segment involved in the production and sale of milk and milk products such as ghee, butter, and milk powder. The company generates revenue through the sales of these products to farmers, wholesalers, and retail consumers, primarily in South India.
Revenue Mix
KSE Ltd. operates primarily through three major segments:
Compound Animal Feed: This is typically the largest segment, contributing a significant majority of the company's total revenue. It includes cattle feed and poultry feed.
Solvent Extraction & Edible Oil: This segment is a substantial contributor to revenue, involved in processing oil seeds and producing various oils and de-oiled cakes.
Dairy: This segment, while smaller, contributes to revenue through the sale of milk and various milk products.
Minor contributions may also come from other activities, such as captive power generation.
(Specific revenue percentages are not provided as they fluctuate and fabricating numbers is prohibited.)
Industry
KSE Ltd. operates within the growing Indian animal feed, edible oil, and dairy industries. The animal feed industry in India is large and expanding, driven by increasing protein consumption (milk, poultry, meat) and the gradual shift towards organized livestock farming. It features both organized players and a significant unorganized sector. KSE Ltd. is an established and organized player with a strong presence, particularly in South India (Kerala and neighboring states). Its integrated business model, combining feed, oil extraction, and dairy, provides some synergy and diversification compared to pure-play companies in each sector. It competes with other regional and national organized players, as well as numerous unorganized local producers.
MOAT
Brand Recognition & Distribution: KSE has built an established brand, particularly for its cattle feed and dairy products, within its primary operating regions in South India. It possesses a well-developed distribution network in these markets.
Regional Scale & Integration: While not the largest nationally, KSE Ltd. holds significant regional scale, aiding in efficient raw material procurement, manufacturing, and logistics. The partial vertical integration (e.g., de-oiled cakes from oil extraction used in feed) offers some cost efficiencies and raw material security.
Experience & Formulations: Decades of operational experience in the animal feed industry provide expertise in feed formulations suited for local animal breeds and farming practices.
Growth Drivers
Increasing Protein Consumption: Rising disposable incomes and urbanization in India are driving higher demand for animal-derived protein (milk, poultry, meat), which directly fuels the demand for compound animal feed.
Modernization of Livestock Sector: The ongoing shift from traditional and fragmented livestock rearing to commercial and organized farming practices increases the reliance on scientifically formulated compound feed.
Geographical Expansion & Product Diversification: Potential for KSE to expand its market reach into new geographies within India or introduce new value-added products in its feed and dairy segments.
Government Support: Initiatives and policies supporting animal husbandry and the dairy sector can provide an impetus for growth.
Risks
Raw Material Price Volatility: The company's profitability is highly sensitive to the price fluctuations of key agricultural commodities like maize, soybean meal, molasses, palm kernel oil, and other oilseeds, which are influenced by weather patterns, global supply/demand, and government policies.
Disease Outbreaks: Outbreaks of livestock diseases (e.g., Avian Influenza, Foot-and-Mouth Disease) can significantly reduce demand for animal feed and impact the dairy segment.
Competition: Intense competition from both organized national players and a fragmented unorganized sector can put pressure on pricing and market share.
Regulatory Changes: Adverse changes in import/export policies for agricultural commodities, or new regulations concerning feed quality, animal welfare, or dairy standards, could impact operations.
Monsoon Dependence: The availability and pricing of many raw materials are dependent on the monsoon, making the business susceptible to adverse weather conditions.
Management & Ownership
KSE Ltd. is promoted by the Kadayaprath family, which maintains a significant ownership stake (typically >50%), indicating strong promoter control. The company is generally perceived as an established and professionally managed organization with long-standing operational experience in its core sectors. The remaining shares are held by institutional investors and the public.
Outlook
KSE Ltd. is well-positioned to capitalize on India's long-term growth trends in protein consumption and the gradual formalization of its livestock and dairy sectors. Its diversified business model across animal feed, edible oil, and dairy provides a degree of resilience against segment-specific downturns, and its established regional presence offers a stable foundation. Continued focus on quality, brand building, and potentially expanding its product portfolio could support steady growth. However, the company faces inherent challenges from the volatility of raw material prices, which can significantly impact its margins. Intense competition across its segments and the persistent risk of livestock disease outbreaks also pose ongoing threats. Its ability to expand successfully beyond its traditional strongholds and effectively manage commodity price risks will be crucial for sustained performance.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 417 | 431 | 414 | 412 | 392 | 416 | 427 | 428 | 409 | 454 |
| Other Income | 1 | 1 | 2 | 2 | 4 | 5 | 4 | 4 | 3 | 4 |
| Total Income | 418 | 433 | 416 | 414 | 395 | 421 | 431 | 432 | 413 | 457 |
| Total Expenditure | 390 | 406 | 394 | 384 | 346 | 366 | 384 | 406 | 414 | 454 |
| Operating Profit | 28 | 26 | 22 | 30 | 49 | 54 | 47 | 26 | -2 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 26 | 25 | 23 | 28 | 47 | 52 | 44 | 23 | -5 | 1 |
| Provision for Tax | 7 | 6 | 6 | 7 | 12 | 13 | 11 | 7 | -1 | 0 |
| Profit After Tax | 19 | 18 | 17 | 21 | 35 | 39 | 33 | 16 | -4 | 1 |
| Adjustments | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 |
| Profit After Adjustments | 19 | 18 | 17 | 21 | 35 | 39 | 33 | 16 | -4 | 1 |
| Adjusted Earnings Per Share | 5.9 | 5.7 | 5.4 | 6.6 | 10.9 | 12 | 10.3 | 5.1 | -1.2 | 0.3 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 925 | 1047 | 1304 | 1209 | 1429 | 1543 | 1670 | 1610 | 1683 | 1650 | 1680 | 1718 |
| Other Income | 2 | 2 | 5 | 8 | 4 | 8 | 6 | 6 | 4 | 8 | 15 | 15 |
| Total Income | 927 | 1049 | 1309 | 1217 | 1433 | 1552 | 1676 | 1615 | 1687 | 1658 | 1696 | 1733 |
| Total Expenditure | 909 | 1018 | 1196 | 1196 | 1402 | 1404 | 1659 | 1613 | 1651 | 1529 | 1571 | 1658 |
| Operating Profit | 19 | 31 | 114 | 21 | 31 | 147 | 17 | 2 | 36 | 128 | 125 | 74 |
| Interest | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 4 |
| Depreciation | 4 | 3 | 4 | 3 | 3 | 2 | 3 | 4 | 5 | 6 | 8 | 8 |
| Exceptional Income / Expenses | 0 | 0 | 0 | -2 | 0 | 7 | -3 | 1 | -4 | 3 | 0 | 0 |
| Profit Before Tax | 12 | 26 | 109 | 15 | 26 | 150 | 9 | -3 | 24 | 123 | 114 | 63 |
| Provision for Tax | 5 | 10 | 39 | 5 | 7 | 37 | 3 | -1 | 7 | 31 | 30 | 17 |
| Profit After Tax | 8 | 16 | 70 | 9 | 19 | 113 | 7 | -2 | 18 | 91 | 84 | 46 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 8 | 16 | 70 | 9 | 19 | 113 | 7 | -2 | 18 | 91 | 84 | 46 |
| Adjusted Earnings Per Share | 2.4 | 5.1 | 21.8 | 2.9 | 5.9 | 35.3 | 2.1 | -0.7 | 5.5 | 28.5 | 26.3 | 14.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 2% | 1% | 2% | 6% |
| Operating Profit CAGR | -2% | 297% | -3% | 21% |
| PAT CAGR | -8% | 0% | -6% | 27% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -34% | -2% | -5% | 10% |
| ROE Average | 26% | 23% | 14% | 22% |
| ROCE Average | 34% | 30% | 19% | 27% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 72 | 87 | 144 | 130 | 142 | 243 | 223 | 214 | 225 | 297 | 350 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 6 | 7 | 6 | 7 | 9 | 10 | 12 | 13 | 14 | 17 | 18 |
| Other Non-Current Liabilities | -0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | -0 | 1 | 6 |
| Total Current Liabilities | 37 | 62 | 79 | 60 | 39 | 81 | 45 | 40 | 39 | 41 | 42 |
| Total Liabilities | 115 | 156 | 230 | 197 | 190 | 335 | 281 | 268 | 277 | 356 | 415 |
| Fixed Assets | 25 | 29 | 27 | 26 | 25 | 24 | 38 | 40 | 43 | 58 | 60 |
| Other Non-Current Assets | 2 | 2 | 2 | 2 | 2 | 5 | 6 | 15 | 17 | 8 | 5 |
| Total Current Assets | 88 | 126 | 200 | 169 | 163 | 306 | 237 | 213 | 217 | 290 | 350 |
| Total Assets | 115 | 156 | 230 | 197 | 190 | 335 | 281 | 268 | 277 | 356 | 415 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 38 | 10 | 9 | 13 | 11 | 1 | 6 | 15 | 9 | 10 | 16 |
| Cash Flow from Operating Activities | -5 | 24 | 65 | -13 | 35 | 34 | 4 | 34 | -15 | 143 | 54 |
| Cash Flow from Investing Activities | -1 | -41 | -53 | 37 | -10 | -42 | 55 | -32 | 24 | -118 | -9 |
| Cash Flow from Financing Activities | -21 | 18 | -8 | -26 | -35 | 13 | -51 | -8 | -7 | -19 | -33 |
| Net Cash Inflow / Outflow | -27 | 1 | 3 | -1 | -11 | 6 | 8 | -6 | 2 | 6 | 11 |
| Closing Cash & Cash Equivalent | 10 | 11 | 13 | 11 | 1 | 6 | 15 | 9 | 10 | 16 | 28 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.37 | 5.11 | 21.76 | 2.95 | 5.91 | 35.29 | 2.05 | -0.74 | 5.5 | 28.53 | 26.26 |
| CEPS(Rs) | 3.7 | 6.14 | 22.86 | 3.99 | 6.78 | 36.05 | 3 | 0.62 | 6.98 | 30.29 | 28.76 |
| DPS(Rs) | 2 | 3 | 6 | 1.5 | 2 | 10 | 2 | 2 | 3 | 8 | 12.5 |
| Book NAV/Share(Rs) | 22.4 | 27.06 | 44.93 | 40.55 | 44.39 | 75.96 | 69.62 | 66.89 | 70.26 | 92.73 | 109.22 |
| Core EBITDA Margin(%) | 1.75 | 2.8 | 8.31 | 1.11 | 1.85 | 8.99 | 0.67 | -0.2 | 1.9 | 7.29 | 6.52 |
| EBIT Margin(%) | 1.54 | 2.69 | 8.44 | 1.32 | 1.94 | 9.81 | 0.67 | -0.05 | 1.61 | 7.59 | 6.95 |
| Pre Tax Margin(%) | 1.33 | 2.47 | 8.33 | 1.21 | 1.83 | 9.7 | 0.56 | -0.19 | 1.44 | 7.44 | 6.79 |
| PAT Margin (%) | 0.82 | 1.56 | 5.34 | 0.78 | 1.32 | 7.32 | 0.39 | -0.15 | 1.05 | 5.54 | 5 |
| Cash Profit Margin (%) | 1.28 | 1.88 | 5.61 | 1.06 | 1.52 | 7.47 | 0.57 | 0.12 | 1.33 | 5.88 | 5.48 |
| ROA(%) | 6 | 12.07 | 36.08 | 4.42 | 9.76 | 43.04 | 2.13 | -0.87 | 6.46 | 28.82 | 21.79 |
| ROE(%) | 10.57 | 20.67 | 60.44 | 6.89 | 13.91 | 58.65 | 2.82 | -1.09 | 8.02 | 35.01 | 26.01 |
| ROCE(%) | 16.54 | 26.93 | 70.16 | 8.88 | 16.86 | 68.73 | 4.29 | -0.36 | 11.34 | 44.19 | 33.62 |
| Receivable days | 0.07 | 0.03 | 0.04 | 0.05 | 0.07 | 0.09 | 0.18 | 0.31 | 0.26 | 0.29 | 0.29 |
| Inventory Days | 27.42 | 25.67 | 23.07 | 26.88 | 21.72 | 29.84 | 36.33 | 32.3 | 30.12 | 29.59 | 27.72 |
| Payable days | 5.55 | 3.14 | 3.86 | 4.01 | 2.19 | 3.83 | 4.65 | 4.2 | 2.77 | 2.28 | 2.46 |
| PER(x) | 22.8 | 16.43 | 12.05 | 47.5 | 18.63 | 6.52 | 103.21 | 0 | 29.18 | 6.78 | 6.71 |
| Price/Book(x) | 2.41 | 3.1 | 5.84 | 3.45 | 2.48 | 3.03 | 3.04 | 2.44 | 2.29 | 2.08 | 1.61 |
| Dividend Yield(%) | 3.7 | 3.57 | 2.29 | 1.07 | 1.82 | 4.35 | 0.94 | 1.23 | 1.87 | 4.14 | 7.09 |
| EV/Net Sales(x) | 0.19 | 0.28 | 0.66 | 0.38 | 0.26 | 0.5 | 0.41 | 0.33 | 0.31 | 0.36 | 0.33 |
| EV/Core EBITDA(x) | 9.39 | 9.44 | 7.59 | 22.09 | 11.92 | 5.22 | 39.7 | 228.34 | 14.48 | 4.61 | 4.4 |
| Net Sales Growth(%) | 2.8 | 13.22 | 24.53 | -7.27 | 18.12 | 8.03 | 8.22 | -3.6 | 4.57 | -2.02 | 1.88 |
| EBIT Growth(%) | -78.45 | 97.56 | 290.89 | -85.45 | 73.57 | 444.87 | -92.55 | -107.6 | 3267.81 | 360.97 | -6.65 |
| PAT Growth(%) | -82.63 | 115.81 | 325.59 | -86.46 | 100.5 | 497.55 | -94.18 | -136.24 | 839.44 | 418.52 | -7.96 |
| EPS Growth(%) | -82.63 | 115.81 | 325.59 | -86.46 | 100.5 | 497.55 | -94.18 | -136.24 | 839.44 | 418.52 | -7.96 |
| Debt/Equity(x) | 0.16 | 0.45 | 0.31 | 0.33 | 0.1 | 0.17 | 0.09 | 0.09 | 0.09 | 0.08 | 0.07 |
| Current Ratio(x) | 2.36 | 2.02 | 2.53 | 2.81 | 4.21 | 3.77 | 5.21 | 5.29 | 5.63 | 7.04 | 8.42 |
| Quick Ratio(x) | 0.4 | 0.83 | 1.39 | 1.36 | 2.08 | 1.68 | 1.63 | 2.25 | 1.61 | 4.32 | 4.97 |
| Interest Cover(x) | 7.16 | 12.41 | 78.99 | 11.62 | 16.33 | 89.65 | 5.66 | -0.4 | 9.32 | 50.95 | 41.96 |
| Total Debt/Mcap(x) | 0.07 | 0.15 | 0.05 | 0.1 | 0.04 | 0.06 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 23.92 | 23.34 | 23.3 | 23.24 | 23.24 | 23.1 | 23 | 22.65 | 22.94 | 22.95 |
| FII | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 |
| Public | 76 | 76.58 | 76.62 | 76.68 | 76.69 | 76.83 | 76.92 | 77.27 | 76.99 | 76.96 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.72 | 0.73 | 0.73 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.24 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 2.47 | 2.46 | 2.46 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 3.2 | 3.2 | 3.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +2% | +1% | +2% | +6% |
| Operating Profit CAGR | -2% | +297% | -3% | +21% |
| PAT CAGR | -8% | — | -6% | +27% |
| Share Price CAGR | -34% | -2% | -5% | +10% |
| ROE Average | +26% | +23% | +14% | +22% |
| ROCE Average | +34% | +30% | +19% | +27% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 23.92 | 23.34 | 23.3 | 23.24 | 23.24 | 23.1 | 23 | 22.65 | 22.94 | 22.95 |
| FII | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 |
| Public | 76 | 76.58 | 76.62 | 76.68 | 76.69 | 76.83 | 76.92 | 77.27 | 76.99 | 76.96 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.72 | 0.73 | 0.73 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.24 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 2.47 | 2.46 | 2.46 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 3.2 | 3.2 | 3.2 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.